Together with the finding here that parietal cell KCNE2 expression appears to be reduced in human gastric cancer tissue (Figure 4) and the previous report that KCNE2 inhibits gastric cancer cell proliferation [12], the data suggest KCNE2 disruption is associated with gastric cancer progression. This evidence concerns the gene KCNE2 and gastric cancer.